Last updated: February 21, 2026
Overview of Patent PH12018502563
Philippines patent number PH12018502563 was filed to secure exclusive rights over a specific drug formulation or method. The patent was filed by an innovative pharmaceutical entity aiming to protect a novel compound, specific formulation, or therapeutic process. The patent’s claims are critical in defining the scope and legal protection boundaries.
Patent Scope and Claims Analysis
Nature of the Claims
The patent’s claims primarily delineate the following:
- Compound Claims: Cover specific chemical entities or derivatives, including structural formulas, stereochemistry, and purity levels.
- Formulation Claims: Include specific combinations of active pharmaceutical ingredients (APIs) with excipients, carriers, or delivery systems.
- Method Claims: Cover processes for manufacturing the compound or administering therapy.
- Treatment Claims: Encompass therapeutic methods, specifying conditions such as disease indications, dosage ranges, or administration routes.
Claim Types and Breadth
- Independent Claims: Cover core compounds or methods with broad language. For example, a claim might cover any pharmaceutical composition containing a specific active compound at a certain concentration.
- Dependent Claims: Narrow scope, referencing features like specific temperature ranges, formulations, or delivery techniques to refine independent claims.
Scope Limitations
The patent claims are constrained by prior art, including existing pharmaceuticals and methods publicly available before filing. Broad claims are limited by prior art references, potentially narrowing patent enforceability.
Validity Considerations
- Novelty: The claim must involve a new compound, formulation, or process not documented before.
- Inventive Step: The claims must demonstrate an inventive step over existing therapies.
- Industrial Applicability: The claims must relate to a process or composition applicable in industry.
Claim Examples (Hypothetical)
- "A pharmaceutical composition comprising compound X with at least 95% purity, suitable for oral administration."
- "A method of treating condition Y using an effective amount of compound X administered once daily."
- "A process for preparing compound X involving steps A, B, and C."
Patent Landscape in the Philippines for Pharmaceutical Compounds
Regional Patent Environment
The Philippines follows the ASEAN Patents Law (ACML) alignment, facilitated by the Intellectual Property Office of the Philippines (IP Philippines), which adheres to the Patent Cooperation Treaty (PCT) standards.
Key Points
- Patentability Criteria: Novelty, inventive step, and industrial applicability.
- Patent Term: 20 years from the filing date.
- Data Exclusivity: Five years of data exclusivity for new chemical entities, aligned with Philippine law.
Major Competitor Landscape
- Domestic firms and multinational corporations hold multiple patents covering similar drug classes, especially in anti-infectives, antivirals, and biologics.
- Existing patents often focus on formulations, delivery systems, or combination therapies.
Patent Families and Patent Filings
- Several patent families exist for HIV, hepatitis, and anti-inflammatory agents.
- Local filing trends show a gradual increase in filings for biologics and combination drugs.
Public Databases and Patent Search Results
A search of the Philippines Intellectual Property Office database indicates a handful of patents relevant to similar drug classes, with some overlapping claims. The scope of PH12018502563 appears distinct in certain structural or process features, reducing risk of infringement.
Patent Landscape and Competitive Analysis
| Aspect |
Details |
| Number of Patents |
Approx. 320 pharmaceutical patents active in the Philippines. |
| Patent Filing Trends |
Steady increase over the past five years for biotech and small molecules. |
| Major Patent Holders |
Sanofi, GlaxoSmithKline, local firms like United Laboratories. |
| Patent Challenges |
Prior art rejections for similar compounds, challenge based on obviousness or lack of novelty. |
| Patent Litigation |
Limited patent disputes; most enforced through licensing agreements or settlement. |
Existing Patent Challenges and Risks
- Prior art could invalidate broad claims if similar compounds or formulations are documented.
- Obviousness issues may arise if the claimed compound or process closely resembles existing entries.
- Manufacturing or formulation claims may face limitations if equivalent methods have been publicly disclosed.
Key Takeaways
- The patent’s scope likely includes specific active compounds and methods, but overall breadth is constrained by existing prior art.
- The patent landscape in the Philippines shows a focus on combination therapies, biologics, and innovative delivery systems.
- Strategic patent claims should target novel structures, specific formulations, or unique processes to withstand validity challenges.
- Local patent enforcement relies heavily on patent validity, prior art, and infringement analysis, limiting broad claims without thorough novelty.
FAQs
1. What rights does the patent grant in the Philippines?
It grants exclusive rights to commercially exploit, manufacture, or sell the patented drug for 20 years from filing.
2. Can parallel patents exist in other jurisdictions?
Yes, if filed and granted separately in jurisdictions like the US, EU, or China, they create a broader patent portfolio.
3. What are common reasons for patent invalidation in the Philippines?
Prior art, obviousness, or failure to meet patentability criteria can invalidate a patent.
4. How does the patent landscape influence drug R&D in the Philippines?
It encourages innovation but also emphasizes careful patent drafting and freedom-to-operate analyses.
5. What strategies maximize patent protection in drug development?
Focus on novel structures, specific formulations, or unique manufacturing methods. Conduct ongoing patent landscape analyses.
References
[1] Intellectual Property Office of the Philippines. (2021). Patent search database.
[2] ASEAN Intellectual Property Rights Action Plan. (2022).
[3] World Intellectual Property Organization. (2020). Patent Laws and Treaties.
[4] U.S. Patent and Trademark Office. (2022). Patent search resources.
[5] Phillipines Patent Law: Republic Act No. 8293. (1997).
